Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02986178
What this trial is testing

Lerapolturev in Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Istari Oncology, Inc. 121
Not applicableActive Not RecruitingNCT07420543
What this trial is testing

Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach

Who this might be right for
Brain Tumors and/or Solid Tumors IncludingGlioblastomaGlioblastoma (GBM)+1 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 30
Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Testing effectiveness (Phase 2)Study completedNCT01564914
What this trial is testing

Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Tracon Pharmaceuticals Inc. 22
Testing effectiveness (Phase 2)Ended earlyNCT01310855
What this trial is testing

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
University College, London 38
Not applicableLooking for participantsNCT04427384
What this trial is testing

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Who this might be right for
Brain Tumor, RecurrentBrain TumorBrain Tumor, Primary+3 more
GT Medical Technologies, Inc. 600
Testing effectiveness (Phase 2)Looking for participantsNCT06220552
What this trial is testing

The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Fifth Affiliated Hospital, Sun Yat-Sen University 20
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Not applicableStudy completedNCT00660543
What this trial is testing

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

Who this might be right for
Adult Brain Glioblastoma
OHSU Knight Cancer Institute 14
Not applicableUnknownNCT05099068
What this trial is testing

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)

Who this might be right for
Advanced / Metastic Solid TumorsGlioblastomaChronic Leukemia Lymphocytic
Centre Leon Berard 500
Testing effectiveness (Phase 2)Study completedNCT01465347
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBMGlioma
Diffusion Pharmaceuticals Inc 59
Testing effectiveness (Phase 2)WithdrawnNCT03014804
What this trial is testing

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaGliosarcomaOligodendroglioma+2 more
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)Study completedNCT06625047
What this trial is testing

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Who this might be right for
Astrocytoma, IDH-MutantGlioblastomaGlioma+1 more
Mayo Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01402063
What this trial is testing

PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation

Who this might be right for
Glioblastoma Multiforme
Brown University 63
Testing effectiveness (Phase 2)WithdrawnNCT00984438
What this trial is testing

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati
Testing effectiveness (Phase 2)Study completedNCT04440358
What this trial is testing

Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

Who this might be right for
Recurrent Glioblastoma
InSightec 13
Not applicableStudy completedNCT00001148
What this trial is testing

Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor

Who this might be right for
AstrocytomaGlioblastomaGlioma
National Institute of Neurological Disorders and Stroke (NINDS) 25
Early research (Phase 1)Looking for participantsNCT05686798
What this trial is testing

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more
Henry Ford Health System 18
Testing effectiveness (Phase 2)Study completedNCT00641706
What this trial is testing

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT01866449
What this trial is testing

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme (GBM) WHO Grade IV
University of Ulm 24
Next Page